Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Paradigm Clinical Research, with three dedicated research sites in California and Colorado, announced it has grown its executive leadership team, bringing on board Travis Milnes as chief financial officer (CFO) and Amy Henderson as head of clinical ...
read more
Thursday, October 06, 2022
ICON plc has been selected by the US Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for Strategic Preparedness and Response (ASPR) in the Department of Health and Human Services (HHS), to execute an anthrax...
read more
Thursday, October 06, 2022
Barentz International, a global life science ingredients distributor, has acquired Viachem, Ltd., a specialty distributor of life science ingredients and specialty chemicals.
read more
Wednesday, October 05, 2022
Absolute Biotech has launched as a unified company joining together leading antibody-centric brands from around the world.
read more
Wednesday, October 05, 2022
Almac Clinical Services announced a new state-of-the-art Cryogenic Service Solution within its Durham, North Carolina campus to support cell and gene therapies.
read more
Wednesday, October 05, 2022
Ginkgo Bioworks made a tuck-in acquisition of Circularis, a biotechnology company with a proprietary circular RNA and promoter screening platform.
read more
Samsung Biologics, a world-leading contract development and manufacturing organization (CDMO), is launching its new proprietary development technology platforms – S-DUAL™ and DEVELOPICK™ – at this year's BioProcess International Conference and ...
read more
The Almac Group announced the appointment of Graeme McBurney to the Board of Directors in the role of Chief Operating Officer effective 1st October 2022.
read more
Quotient Sciences, a drug development and manufacturing accelerator, completed major investments and expansions at its Nottingham, UK and Reading, UK, facilities to support the delivery of fully integrated drug development programs through the ...
read more
Thursday, September 22, 2022
AbCellera launched the second phase of its global headquarters expansion by breaking ground on its new facility in Vancouver, Canada.
read more
Thursday, September 22, 2022
Kaléo announced the execution of the first contract with the U.S. Department of Defense (DoD) for the procurement of the Rapid Opioid Countermeasure System (ROCS), a 10 mg Naloxone Auto-injector (naloxone hydrochloride injection) antidote for ultra-...
read more
Thursday, September 22, 2022
Catalent, a leader in enabling biopharma, cell, gene, and consumer health partners to optimize the development, launch, and supply of better patient treatments across multiple modalities, announced that it has reached an agreement to acquire Metrics ...
read more
Thursday, September 22, 2022
Peli BioThermal extends service centers in Japan with a new facility, situated near Tokyo’s international Narita Airport.
read more
Thursday, September 22, 2022
Bora Pharmaceutical Labs, a division of Bora Pharmaceuticals, partnered with TaiRx, a Taiwanese drug development company, to manufacture a novel anticancer drug, CVM-1118.
read more
Wednesday, September 21, 2022
Alliance Pharma hired four new leaders, bringing on a new Chief Operating Officer (COO), Chief Commercial Officer (CCO), Chief Financial Officer (CFO), and Chief People Officer (CPO). These leaders will support continued global expansion, which ...
read more